Trials / Unknown
UnknownNCT04836871
Double Filtration Plasmapheresis Combined With Chemotherapy
Clinical Research of Double Filtration Plasmapheresis Combined With Chemotherapy to Remove M Protein in Multiple Myeloma
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Fuling Zhou · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of double filtration plasmapheresis combined with chemotherapy for the treatment of abnormalities of M protein or renal function due to the multiple myeloma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | DFPP combined with chemotherapy | Double filtration plasmapheresis combined with chemotherapy |
Timeline
- Start date
- 2021-05-15
- Primary completion
- 2024-04-30
- Completion
- 2024-10-31
- First posted
- 2021-04-08
- Last updated
- 2023-07-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04836871. Inclusion in this directory is not an endorsement.